Hepatocellular carcinoma effectively treated by intravenous infusion of cisplatin

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 7, Issue 2, 2000, Pages 218-221

  Ishikawa, Masashi ^a,b   Yogita, Sirou ^a   Miyake, Hidenori ^a   Fukuda, You ^a   Harada, Masamitsu ^a   Wada, Daisuke ^a   Tashiro, Seiki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Cisplatin; Hepatocellular carcinoma; Lung metastases; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ARTICLE; CASE REPORT; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; LUNG TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INFUSIONS, INTRAVENOUS; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0033642855     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340050179     Document Type: Article

References (16)

1. Okada S (1998) Chemotherapy in hepatocellular carcinoma. Hepatogastroenterology 45:1259-1263
2. Melia W, Westaby D, Williams R (1981) Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma. Clin Oncol 7:275-280
3. Cheng E, Watson RC, Fortner J, Kemeny N, Golbey R (1982) Regional intraarterial infusion of cisplatin in primary liver cancer. A phase II trial (Abstr C-695). Proc Am Soc Clin Oncol 7:179
4. Rosenberg B, Camp LV, Krigas T (1965) Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205:698-699
5. Kies MS, Rosen ST, Tsang TK, Shetty R, Schneider PA, Wallemark CB, Shields TW (1987) Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. 60:2156-2160
6. Vohes EE, Mick R, Lester EP, Panno WR, Weichselbaum RR (1991) Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution J Clin Oncol 9:1376-1384
7. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K (1984) The natural history of hepatocellular carcinoma: a study of 100 untreated cases. Cancer 54:1461-1465
8. Onohara S, Kobayashi H, Itoh Y, Shinohara S (1988) Intraarterial cis-platinum infusion with sodium thiosulfate protection and angiotensin II induced hypertension for treatment of hepatocellular carcinoma. Acta Radiol 29:197-202
9. Ikeda K, Saitoh S, Koida I, Tsubota A, Arase Y, Chayama K, Kumada H (1995) A prospective randomized evaluation of a compound of tegafur and uracil as adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Am J Clin Oncol 18:204-210
10. Ravry MJ, Omura GA, Bartolucci AA (1986) Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma. A Southeastern Cancer Study Group trial. Cancer Treat Rep 70:311-312
11. Epstein B, Ettinger D, Leichner PK, Order SE (1990) Multimodality cisplatin treatment in nonresectable alpha-fetoprotein-positive hepatoma. Cancer 67:896-900
12. Kajanti M, Rissanen P, Vikkunen P, Franssilak, Mantyla M (1986) Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma. Cancer 58:2386-2388
13. Falkson G, Ryan LM, Johnson LA, Simson IU, Coetzer BJ, Carbone PP, Creech RH, Schutt AJ (1987) A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study. Cancer 60:2141-2145
14. Okada S, Okazaki N, Nose H, Shimada Y, Yoshimori M, Aoki K (1993) A phase II study of cisplatin in patients with hepatocellular carcinoma. Oncology 50:22-26
15. Dexter DL, Leith JT (1986) Tumor heterogeneity and drug resistance. J Clin Oncol 4:244-257
16. Ota K, Taguchi T, Kimura K (1987) Report on nationwide pooled data and cohort investigation in UFT phase II study. Jpn J Cancer Chemother 14:2749-2757